A peptide ETB receptor antagonist
Related Products
Alternative(s)
17403BQ-788 (sodium salt)
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

BQ-788

Item No. 31156

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Formal Name
N-[(cis-2,6-dimethyl-1-piperidinyl)carbonyl]-4-methyl-L-leucyl-1-(methoxycarbonyl)-D-tryptophyl-D-norleucine
CAS Number
173326-37-9
Molecular Formula
C34H51N5O7
Formula Weight
641.8
Purity
≥90%
Formulation (Request formulation change)
A solid
Solubility(Learn about Variance in Solubility)
DMSO: 10 mM
λmax
229 nm
SMILES
C[C@H]1CCC[C@@H](C)N1C(N[C@@H](CC(C)(C)C)C(N[C@@H](C(N[C@H](CCCC)C(O)=O)=O)CC2=CN(C(OC)=O)C3=CC=CC=C23)=O)=O
InChi Code
InChI=1S/C34H51N5O7/c1-8-9-16-25(31(42)43)35-29(40)26(18-23-20-38(33(45)46-7)28-17-11-10-15-24(23)28)36-30(41)27(19-34(4,5)6)37-32(44)39-21(2)13-12-14-22(39)3/h10-11,15,17,20-22,25-27H,8-9,12-14,16,18-19H2,1-7H3,(H,35,40)(H,36,41)(H,37,44)(H,42,43)/t21-,22+,25-,26-,27+/m1/s1
InChi Key
LPAHKJMGDSJDRG-DJYQTOCQSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    500 µg

    $98

    Add

    1 mg

    $186

    Add

    5 mg

    $735

    Add

    10 mg

    $1,077

    Add
    Cayman Chemical
    Neutrophil Biology Wall Poster

    Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.

    DOWNLOAD NOW
    Product Description

    BQ-788 is a peptide endothelin type B (ETB) receptor antagonist (IC50 = 1.2 nM).1 It is selective for ETB over ETA receptors (IC50 = 280 nM), as well as angiotensin, calcitonin, or neuropeptide receptors at 10 µM. BQ-788 inhibits calcium mobilization induced by endothelin-1 (ET-1) in human Girrardi heart cells (IC50 = 0.54 nM) and vasoconstriction induced by the ETB-selective agonist BQ-3020 in isolated rat pulmonary arteries (pA2 = 8.4).2 In vivo, BQ-788 (1 mg/kg, i.v.) inhibits ET-1-induced depressor responses and induces pressor responses in rats. It protects against laparotomy and surgical gut handling-induced inhibition of intestinal motility in rats.3 BQ-788 also attenuates delayed hypotension, vascular hyporeactivity to norepinephrine, and hepatocellular injury and dysfunction in a rat model of LPS-induced endotoxemia.4

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Okada, M., and Nishikibe, M. BQ-788, a selective endothelin ETB receptor antagonist. Cardiovasc. Drug Rev. 20(1), 53-66 (2002).

    2. Ishikawa, K., Ihara, M., Noguchi, K., et al. Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc. Natl. Acad. Sci. USA 91(11), 4892-4896 (1994).

    3. Ługowska-Umer, H., Umer, A., Kuziemski, K., et al. The protective effect of endothelin receptor antagonists against surgically induced impairment of gastrointestinal motility in rats. J. Smooth Muscle Res. 55, 23-33 (2019).

    4. Ruetten, H., and Thiemermann, C. Effect of selective blockade of endothelin ETB receptors on the liver dysfunction and injury caused by endotoxaemia in the rat. Br. J. Pharmacol. 119(3), 479-486 (1996).